G
Pill imprint G has been identified as Pergolide mesylate 0.05 MG.
Pergolide is used in the treatment of hyperprolactinemia; tourette's syndrome; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy.
Pergolide 0.05 MG is not subject to the Controlled Substances Act.
See also related documents.
Pergolide mesylate Images
- Imprint:
-
G
- Strength:
- 0.05 MG
- Color:
- Yellow
- Size:
- 19.00 mm
- Shape:
- Rectangle
- Availability:
- Prescription only
- Inactive Ingredients:
- glyceryl behenate
magnesium stearate
mannitol
microcrystalline cellulose
ferric oxide yellow
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00172-4520
Advertisement
More PERGOLIDE MESYLATE resources
- Pergolide Mesylate (Wolters Kluwer)
- pergolide (Cerner Multum)
- pergolide (Micromedex) - Includes Dosage Information
- Pergolide Mesylate (AHFS DI)
- Pergolide (FDA)
Search Again
